Gene Therapy 'Cassettes' Could Speed, Cheapen Manufacturing, Gottlieb Says
US FDA Commissioner teases endpoints, suggests accelerated approval plan and post-marketing considerations for gene therapies targeting hemophilia.
US FDA Commissioner teases endpoints, suggests accelerated approval plan and post-marketing considerations for gene therapies targeting hemophilia.